Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis

Conditions:   Lung Neoplasm Malignant;   Interstitial Lung Disease Interventions:   Drug: Prolonged glucocorticosteroid (prednisone) regimen;   Drug: Short glucocorticosteroid (prednisone) regimen Sponsor:   National Institute for Tuberculosis and Lung Diseases, Poland Not yet recruiting

Source: ClinicalTrials.gov - July 30, 2019 Category: Research Source Type: clinical trials